Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (221-230 of 738) with videos related to

Pageof 74
Sort By:
American Journal of Obstetrics and Gynecology|November 1, 1994
Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.
Gynecologic Oncology|October 24, 2022
Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancerMaria Rubinstein, Sherry Shen, Bradley J Monk, et al.
Gynecologic Oncology|November 4, 2008
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancerTroy A Gatcliffe, Krishnansu S Tewari, Amy Shah, et al.
Journal of Geriatric Oncology|June 9, 2023
Robotic-assisted gynecologic surgery in an older population: A comparison studyMadison S Moore, Elise H Vo, Bikash Bhattarai, et al.
The Oncologist|April 12, 2014
Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysisJohn K Chan, Thomas J Herzog, Lilian Hu, et al.
Journal of the American College of Surgeons|January 5, 2002
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancerN Gillette-Cloven, R A Burger, B J Monk, et al.
Gynecologic Oncology|March 20, 2021
Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysisZachary Alholm, Bradley J Monk, Jie Ting, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancerK Tewari, F Cappuccini, A M Syed, et al.
Journal of the National Cancer Institute|October 2, 1996
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group StudyHoward D Homesley, Virginia Filiaci, Maurie Markman, et al.
Pageof 74

Showing results (221-230 of 738) with videos related to

Sort By:
Pageof 74
American Journal of Obstetrics and Gynecology|November 1, 1994
Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.
Gynecologic Oncology|October 24, 2022
Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancerMaria Rubinstein, Sherry Shen, Bradley J Monk, et al.
Gynecologic Oncology|November 4, 2008
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancerTroy A Gatcliffe, Krishnansu S Tewari, Amy Shah, et al.
Journal of Geriatric Oncology|June 9, 2023
Robotic-assisted gynecologic surgery in an older population: A comparison studyMadison S Moore, Elise H Vo, Bikash Bhattarai, et al.
The Oncologist|April 12, 2014
Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysisJohn K Chan, Thomas J Herzog, Lilian Hu, et al.
Journal of the American College of Surgeons|January 5, 2002
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancerN Gillette-Cloven, R A Burger, B J Monk, et al.
Gynecologic Oncology|March 20, 2021
Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysisZachary Alholm, Bradley J Monk, Jie Ting, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancerK Tewari, F Cappuccini, A M Syed, et al.
Journal of the National Cancer Institute|October 2, 1996
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group StudyHoward D Homesley, Virginia Filiaci, Maurie Markman, et al.
Pageof 74